Abstract: With the increasing demand for power levels in medium and low voltage applications such as ships and warships, wind power generation systems. The multiphase generators are receiving the ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

I’ve been involved with the Rebelle Rally since its inception in 2016, either as a competitor or live show host, and over the ...

In our strange new AI reality, I put the top AI video generators to the test to find the ultimate winner. Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and ...

One year after the launch of the Runaki Project - meaning “light” in Kurdish - an ambitious initiative designed to provide 24 ...

CoreWeave (CRWV) shares rose 1% in extended trading on Monday after the data center company reported fiscal third-quarter ...

The Confederated Tribes of the Colville Reservation in northern Washington state and OATI will install four solar and energy ...